Fondazione Policlinico Gemelli IRCCS
Welcome,         Profile    Billing    Logout  
 48 Trials 
103 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Piperno-Neumann, Sophie
TANGENT, NCT05417789: Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

Recruiting
3
128
Europe, Canada, US, RoW
Emactuzumab, Placebo
SynOx Therapeutics Limited
TGCT
04/26
09/27
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
SARCOME13, NCT03643133 / 2017-001165-24: Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients

Active, not recruiting
2
60
Europe
Mifamurtide, MEPACT, EI or M-API regimen depending on patient age
UNICANCER
Osteosarcoma
03/25
10/33
REGOBONE, NCT02389244 / 2013-003910-42: A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas

Checkmark Data from REGOBONE trial for relapsed advanced or metastatic chordoma at ESMO 2021
Jul 2021 - Jul 2021: Data from REGOBONE trial for relapsed advanced or metastatic chordoma at ESMO 2021
Active, not recruiting
2
163
Europe
Regorafenib, Stivarga, Placebo, Placebo tablet
UNICANCER
Ewing Sarcomas, Chondrosarcomas, Osteosarcomas, Chondroma, CIC-Rearranged Sarcoma
10/24
06/25
IDE196-009, NCT05907954: (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Recruiting
2
82
Europe, Canada, US, RoW
Darovasertib, IDE196, LXS196
IDEAYA Biosciences
Uveal Melanoma
01/26
01/29
CAMPFIRE, NCT05999994: A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Recruiting
2
105
Europe, Japan, US, RoW
Ramucirumab, LY3009806, Cyclophosphamide, Vinorelbine, Gemcitabine, LY188011, Docetaxel, Abemaciclib, LY2835219, Irinotecan, Temozolomide
Eli Lilly and Company
Neoplasms, Child, Adolescent
05/27
05/27
REGOMAIN, NCT04698785: Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

Recruiting
2
36
Europe
Treatment by regorafenib and best supportive care, Experimental arm
Centre Leon Berard
Bone Sarcoma, Osteosarcoma
07/26
07/26
COTESARC, NCT04216953: MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

Active, not recruiting
1/2
320
Europe
Cobimetinib, GDC-0973, Atezolizumab, RO5541267
Centre Leon Berard
Sarcoma,Soft Tissue
02/26
02/27
NCT04879017: FHD-286 in Subjects With Metastatic Uveal Melanoma

Terminated
1
76
Europe, US
FHD-286
Foghorn Therapeutics Inc.
Metastatic Uveal Melanoma
11/23
11/23
REGOSTA, NCT04055220 / 2018-004045-16: Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Recruiting
N/A
168
Europe
Treatment by Regorafenib, Stivarga, Treatment by Placebo, Standard of care
Centre Leon Berard
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma, Chondrosarcoma, Undifferentiated Pleomorphic Sarcoma, Leiomyosarcoma, Angiosarcoma
10/26
10/26
SALOME, NCT04424719: Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse

Recruiting
N/A
700
Europe
Blood test, MRI in routine
Institut Curie
Uveal Melanoma
07/35
07/35
OPTISARC, NCT05272358: Economic Evaluation of Sarcoma Patients Management in France

Recruiting
N/A
2431
Europe
NETSARC network
Centre Leon Berard, École nationale supérieure des Mines Saint-Etienne France, Rennes University Hospital, Assistance Publique - Hôpitaux de Paris
Sarcoma
06/22
02/24
Capogna, Giorgio
NCT04749186: Achieving Lumbar Epidural Block Competency in Inexperienced Trainees After a Structured Teaching Model

Enrolling by invitation
N/A
15
Europe
Compuflo Epidural Training Instrument, Eye tracking glasses, Standardized educational videorecordings, Epidural Simulator
European e-Learning School in Obstetric Anesthesia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Educational Problems
09/22
09/22
NCT05309434: Effects of CPR Coaching on Leader's Performance During Simulated Cardiac Arrest

Not yet recruiting
N/A
40
Europe
Coach
European e-Learning School in Obstetric Anesthesia
Leadership
09/22
10/22
NCT04776382: Eye Movement Modeling Examples as a Teaching Tool

Enrolling by invitation
N/A
15
Europe
EMME (Eye Movement Modeling Examples)
European e-Learning School in Obstetric Anesthesia
Simulation Training
10/22
10/22
Jamal, Rahima
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
NCT01676649: Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Active, not recruiting
2
30
Canada
Ipilimumab, YERVOY, Carboplatin, Paclitaxel
Jewish General Hospital
Untreated Stage III Melanoma or Stage IV Melanoma
02/17
05/26
NCT02617849: Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

Active, not recruiting
2
30
Canada
Pembrolizumab, MK3475, Carboplatin, Paclitaxel
Wilson Miller
Metastatic Malignant Melanoma
12/21
12/25
Canbiome2, NCT06623461: LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

Recruiting
2
128
Canada
Standard of Care Immune Checkpoint Blockade, LND101
Canadian Cancer Trials Group, Canadian Institutes of Health Research (CIHR), Canadian Cancer Society (CCS), Weston Family Foundation
Melanoma
12/28
12/29
NCT04836195: Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma

Completed
1
29
Canada
PCLX-001 - 20mg, zelenirstat, PCLX-001 - 40mg, PCLX-001 - 70mg, PCLX-001 - 100mg, PCLX-001 - 140mg, PCLX-001 - 210mg, PCLX-001 - 280mg
Pacylex Pharmaceuticals, Ozmosis Research Inc.
B-cell Non Hodgkin Lymphoma, Advanced Solid Tumor
10/24
10/24
NCT04862260: Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Active, not recruiting
1
3
Canada
Cholesterol metabolism disruption, A combination of a lipophilic statin (Atorvastatin, Lipitor), a NPC1L1 inhibitor (Ezetimibe, Ezetrol) and a PCSK9 inhibitor (Evolocumab, Repatha) with chemotherapy in pancreatic cancer
CHU de Quebec-Universite Laval, Canadian Institutes of Health Research (CIHR), Biovalorem
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer, Metastatic Cancer
01/25
12/26
Neidhardt, Eve-Marie
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
ABORL, NCT03356223: Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6

Completed
2
25
Europe
Abemaciclib
Centre Leon Berard
Head and Neck Cancer, Advanced Cancer, Metastatic Cancer
11/22
12/22
EBIN, NCT03235245 / 2017-002887-42: Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

Active, not recruiting
2
271
Europe
Nivolumab + Ipilimumab, Encorafenib + Binimetinib
European Organisation for Research and Treatment of Cancer - EORTC
Unresectable Stage III Melanoma, Stage IV Melanoma
10/23
01/27
MOST plus, NCT02029001: Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Recruiting
2
900
Europe
Nilotinib (400 mg BID), Open cohort, Everolimus (10 mg QD), Closed cohort, Sorafenib (400 mg BID), Lapatinib (1500 mg QD), Pazopanib (800 mg QD), Olaparib (300 mg BID), Durvalumab + Tremelimumab
Centre Leon Berard, National Cancer Institute, France
Malignant Solid Neoplasms
01/26
10/27
PROFILER, NCT01774409: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer

Recruiting
N/A
10000
Europe
Blood and tumor samples
Centre Leon Berard
Neoplasms
07/25
07/26
MelBase, NCT02828202: Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Recruiting
N/A
6000
Europe
Biological, Tissular, Quality of life
Assistance Publique - Hôpitaux de Paris, National Cancer Institute (NCI)
Malignant Melanoma
03/26
03/26
Tringali, Andrea
NCT06686810: Endoscopy and Primary Sclerosing Cholangitis

Completed
N/A
118
Europe
Endoscopic Retrogradade CholangioPancreatography (ERCP)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Primary Sclerosing Cholangitis (PSC)
11/24
11/24
STEBINANSIED, NCT05761483: Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.

Recruiting
N/A
40
Europe
ERCP, Biliary stents placement
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Transplant Disorder, Ischemic Cholangiopathy, Non-anastomotic Biliary Stricture, Biliary Stricture, Biliary Stents (Plastic)
10/26
01/28
PROTESIED, NCT05761496: Metal and Plastic Biliary Stents to Drain Malignant Distal Biliary Strictures.

Completed
N/A
871
Europe
Biliary stents insertion
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Biliary Stricture, Stent Stenosis
07/22
12/22
Walker, John R
STOP-GAP, NCT02821013: Duration of Anti-PD-1 Therapy in Metastatic Melanoma

Recruiting
3
614
Canada, RoW
Intermittent PD-1 inhibitor therapy, Continuous PD-1 inhibitor therapy
Canadian Cancer Trials Group, Melanoma and Skin Cancer Trials Limited
Unresectable/Metastatic Melanoma
12/27
12/29
NOD, NCT06633900: Naltrexone for Overdose Prevention

Recruiting
2/3
100
US
IM naltrexone, Usual Care
University of California, San Francisco, National Institute on Drug Abuse (NIDA)
Overdose Accidental
04/27
04/27
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
LATENT, NCT03357757: Avelumab With Valproic Acid in Virus-associated Cancer

Active, not recruiting
2
39
Canada
Valproic Acid, Avelumab
AHS Cancer Control Alberta, EMD Serono
Cancer That is Associated With a Chronic Viral Infection, p16 Positive SCCHN, Squamous Cell Carcinoma of the Cervix, p16 Positive Squamous Cell Carcinoma of the Vagina or Vulva, p16 Positive Squamous Cell Carcinoma of the Penis, p16 Positive Squamous Cell Carcinoma of the Anus or Anal Canal, EBER Positive NPC, EBER Positive Hodgkins and Non-hodgkins Lymphona
03/22
02/27
UNSCARRed, NCT03737721: The Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy

Active, not recruiting
2
20
Canada
Avelumab and Radical radiotherapy
AHS Cancer Control Alberta, EMD Serono, Alberta Cancer Foundation
Squamous Cell Carcinoma of the Skin
11/22
12/24
ACT-FAST, NCT04461418: Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases

Recruiting
2
20
Canada
Glucocorticoid therapy
AHS Cancer Control Alberta
Brain Metastases, Adult
09/24
09/25
CURB-2, NCT05262270: Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder

Recruiting
2
426
US
Extended-Release Naltrexone, XR-NTX, Extended Release Buprenorphine, XR-BUP, Placebo (PLB) Injectable matched to XR-NTX, Injectable matching (to XR-NTX) placebo, Placebo (PLB) Injectable matched to XR-BUP, Injectable matching (to XR-BUP) placebo
University of Texas Southwestern Medical Center, National Institute on Drug Abuse (NIDA)
Cocaine Use Disorder
06/25
09/26
NCT04614584: Mirtazapine and Methamphetamine Drug-drug Interaction Study

Completed
1
15
US
Mirtazapine, Methamphetamine
San Francisco Department of Public Health, University of California, Los Angeles
Methamphetamine Use Disorder, Drug Interaction, Cardiovascular Abnormalities
05/24
05/24
Scambia, Giovanni
NCT04460807 / 2018-000693-30: Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Terminated
3
23
Europe
Exemestane, Mestane, Placebo oral tablet
Ente Ospedaliero Ospedali Galliera, Istituto Di Ricerche Farmacologiche Mario Negri, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Federation of Italian Cooperative Oncology Groups
Ovarian Cancer
04/23
04/23
NCT02584478 / 2021-003871-32: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Active, not recruiting
3
294
Europe, US, RoW
AL3818, Anlotinib Hydrochloride, Anlotinib, Catequentinib, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD), Topotecan, Daily Topotecan, Weekly Topotecan, Carboplatin, Paraplatin, Taxol
Advenchen Laboratories, LLC, Advenchen Laboratories, LLC
Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Cervical Carcinoma
10/24
12/24
FLORA-4, NCT04498117 / 2020-002270-26: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Active, not recruiting
3
615
Europe, Canada, US, RoW
Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo
CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd
Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms
09/25
08/27
NUVOLA, NCT04261465: TRIAL Open-label Multicentre Study

Recruiting
2
35
Europe
Olaparib, Lynparza, Paclitaxel, Carboplatin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
High Grade Serous Ovarian Cancer
12/20
12/22
PYNNACLE, NCT04585750: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

Recruiting
1/2
230
Europe, US, RoW
rezatapopt, PC14586, pembrolizumab, KEYTRUDA®, MK-3475, KEYNOTE-D79, MK-3475-D79
PMV Pharmaceuticals, Inc, Merck Sharp & Dohme LLC
Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor, Lung Cancer, Ovarian Cancer, Endometrial Cancer, Prostate Cancer, Colorectal Cancer, Breast Cancer, Other Cancer, Locally Advanced, Head and Neck Cancer, Gall Bladder Cancer, Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Small Cell Lung Carcinoma, NSCLC, NSCLC (Non-small Cell Lung Cancer), SCLC, Non-Small Cell Lung Carcinoma, Triple Negative Breast Cancer, TNBC, HER2+ Breast Cancer, Non-Small Cell Lung Cancer, ER/PR Positive Breast Cancer, HER2- Breast Cancer, HER2-positive Breast Cancer, HER2-negative Breast Cancer, ER/PR(+), Her2(-) Breast Cancer
03/26
07/26
GO-VAC, NCT04584957: Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)

Active, not recruiting
N/A
196
Europe
VAC therapy
Catholic University of the Sacred Heart
Wound Infection, Gynecologic Cancer
09/21
09/21
MYLUNAR, NCT04123158: MYometrial Lesion UltrasouNd And mRi

Completed
N/A
2353
Europe
Ultrasound, MRI
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Prof. Antonia Testa, Dr. Daniela Romualdi, Dr. Francesca Ciccarone
Sarcoma Uterus
12/23
12/23
CLESS, NCT04178876: Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( )

Recruiting
N/A
64
Europe
ethanol sclerotherapy, stripping technique
Catholic University of the Sacred Heart
Endometrioma
11/22
06/23
FPG-500, NCT06020625: Mutational Oncology in Clinical Practice

Recruiting
N/A
20000
Europe
Diagnostic Test
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Genome Instability, Genetic Predisposition to Disease, Gene Rearrangement
05/23
01/32
NCT04291612: Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Recruiting
N/A
1400
Europe, US, RoW
Physical exam
Memorial Sloan Kettering Cancer Center
Endometrial Cancer, Endometrioid Adenocarcinoma, Endometrial Cancer Stage I
02/25
02/25
R-LYNUS, NCT06621823: Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies

Recruiting
N/A
160
Europe
image-guided surgery technique
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lymph Node Metastasis, Gynecologic Cancer
12/24
05/26
G-AYA, NCT06594471: Comprehensive Assessment of Clinical Characteristics and Outcomes of Gemelli Adolescents and Young Adults

Not yet recruiting
N/A
500
Europe
Questionnaire on late-term physical effects, Questionnaire on sexual and reproductive health outcomes, Questionnaire on psychological outcomes, Questionnaire on social outcomes
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gynecologic Cancer
09/39
03/40
LYSE, NCT06619002: Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies

Recruiting
N/A
100
Europe
Sentinel lymph node sampling, sentinel lymph node detection, sentinel lymph node dissection, sentinel lymph node biopsy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IHU Strasbourg, University Hospital, Strasbourg
Endometrial Cancer, Cervical Cancer, Deep Learning, Artificial Intelligence
09/26
09/27
LASH, NCT06416748: Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer

Recruiting
N/A
974
Europe
Minimally invasive simple hysterectomy, simple hysterectomy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancer, Cervix Cancer
07/27
07/30
GEN&RARE, NCT06926127: Genomic Profiling of Genetic and Rare Diseases

Recruiting
N/A
1500
Europe
Whole Exome Sequencing (WES)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rare Diseases, Genetic Disease
04/26
02/30
Immuno-Gyn, NCT06737640: Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer

Not yet recruiting
N/A
90
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancer, Endometrial Cancer
12/25
12/26
SOLAR, NCT06832397: Detection of Peritoneal Metastases by Diagnostic LAparoscopy in Patients With Locally Advanced Cervical Carcinoma

Not yet recruiting
N/A
120
Europe
Diagnostic laparoscopy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancer
02/28
02/31
STORY, NCT06802198: A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes

Not yet recruiting
N/A
500
Europe
total hysterectomy, subtotal hysterectomy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fibroid Uterus, Metrorrhagia, Adenomyosis, Benign Gynecologic Neoplasm, Endometriosis, Abnormal Uterine Bleeding
02/28
02/30
IMMUNO_ASSAY, NCT06797479: Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.

Not yet recruiting
N/A
12
NA
Blood samples for the analysis of sildenafil in plasma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gynecological Cancer, Immunotherapy
03/30
12/30
MIPEX, NCT06867445: Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence

Recruiting
N/A
64
Europe
Minimally invasive pelvic exenteration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancers, Vaginal Cancers
03/28
03/31
TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting
N/A
48
Europe
Tumor biopsy, Blood sampling
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organoids, Epithelial Ovarian Cancer
11/21
05/23
Nobile, Stefano
FUSID, NCT06031025: Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.

Recruiting
N/A
71
Europe
Questionnaire, clinical examination
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Functional Gastrointestinal Disorders, Gastroesophageal Reflux, Constipation - Functional, Diarrhea, Dyschezia, Colic, Infantile, Vomiting; Cyclical
09/25
09/25
NCT05760274: Esophageal pH-MII Duration: 12 or 24 Hours?

Completed
N/A
127
Europe
multichannel intraluminal impedance and pH monitoring (MII/pH)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gastro Esophageal Reflux
02/25
02/25
NCT06273202: Ultrasound Monitoring of Muscle Thickness in Premature Patients

Active, not recruiting
N/A
24
Europe
Infant Massage
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Prematurity
06/25
09/25
COLF, NCT05793723: Long-term Respiratory Complications in Infants With Perinatal COVID-19

Active, not recruiting
N/A
40
Europe
Pulmonary function testing device
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
COVID-19, Infant, Newborn, Diseases, Respiratory Function Tests
05/25
05/25
ARTE, NCT06443515: Respiratory Trends During Blood Transfusions in Newborns.

Recruiting
N/A
71
Europe
lung ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Blood Transfusion Complication, Blood Transfusion Associated Adverse Reactions, Respiratory Complication, Respiratory Morbidity
12/25
01/26
ELFIGO, NCT06919757: Early Lung Function Trajectories: Comparison Between Infants With and Without Intrauterine Growth Restriction.

Not yet recruiting
N/A
54
Europe
fetal ultrasound to assess lungs, heart and diaphragm, lung function tests
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Intrauterine Growth Retardation (IUGR), Lung Function Tests, Preterm Infant, Respiratory Monitoring
03/27
03/27
Baurain, Jean Francois
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
NCT06433219: Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

Recruiting
2
60
Europe, US, RoW
Tuvusertib (M1774), M1774, VXc-400, VRT-1363004, substance code MSC2584415A, Niraparib, GSK3985771, MK-4827, Lartesertib (M4076), M4076, substance code MSC2585823A
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Ovarian Cancer
01/28
01/28
Teofili, Luciana
BORN, NCT05100212: umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity

Completed
2
146
Europe
cord blood-RBC concentrates, cord blood packed RBC, adult donor RBC concentrates, adult donor packed RBC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Fresenius Kabi
Retinopathy of Prematurity
01/25
01/25
ATREMA, NCT04355130: Autologous Tansfusion REquirements in Bone MArrow Harvest: The Study

Completed
N/A
7
Europe
Iron, vitamin B12 and acid folic supplementation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Bone Marrow Donors
12/22
12/22
DILEMMA, NCT05835726: Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.

Recruiting
N/A
188
Europe
Daratumumab, Darzalex
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Multiple Myeloma, Daratumumab, Autologous Stem Cell Transplantation, Leukapheresis
12/23
04/24
BLEED, NCT05835882: Blood Salvage From Liver Donors: a Feasibility Pilot Study

Recruiting
N/A
25
Europe
Red Blood Cell concentrates from organ donor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Transplantation, Erythrocyte Transfusion
12/24
06/25
ICARUS-2, NCT06637137: Patient Blood Management in Patients Scheduled for Cardiac Surgery

Recruiting
N/A
464
Europe
Iron, folic acid, b vitamin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Anemia, Anemia, Iron-Deficiency, Iron Deficiency Anemia Treatment, Iron Deficiency Anemia (IDA), Cardiac Surgical Patients, Blood Loss, Surgical
02/27
02/27
Marchetti, Claudia
MITO32, NCT04421547 / 2019-001623-12: Efficacy of Letrozole in Recurrent Ovarian Cancer

Terminated
3
86
Europe
Letrozole 2.5mg, Standard single agent chemotherapy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Epionpharma S.r.l.
Epithelial Ovarian Cancer
11/24
11/24
NUVOLA, NCT04261465: TRIAL Open-label Multicentre Study

Recruiting
2
35
Europe
Olaparib, Lynparza, Paclitaxel, Carboplatin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
High Grade Serous Ovarian Cancer
12/20
12/22
MITO36, NCT04887961: Reprab Study: PLD + Trabectedin Rechallenge

Recruiting
2
64
Europe
PLD and Trabectedin rechallenge
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Relapsed Ovarian Cancer
04/22
04/22
BeLIVE, NCT06836219: Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario

Recruiting
N/A
300
Europe
Consorzio Oncotech
Ovarian Cancer
01/29
01/29
DISC-OVARY, NCT06497270: A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the Trial

Active, not recruiting
N/A
3
Europe
Theca and Granulosa Cell Isolation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
BRCA Mutation, Estrogen Deficiency, Surgical Menopause, Menopause Related Conditions, Menopause, Premature, Ovarian Cancer
06/26
06/27
Immuno-Gyn, NCT06737640: Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer

Not yet recruiting
N/A
90
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancer, Endometrial Cancer
12/25
12/26
TUBA-WISP II, NCT04294927: TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

Recruiting
N/A
3000
Europe, US, RoW
Risk-reducing salpingectomy with delayed oophorectomy, Risk-reducing salpingo-oophorectomy
University Medical Center Nijmegen
BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation, BRIP1 Gene Mutation, Ovarian Cancer
02/40
02/40
corsi, filippo
ICARUS-2, NCT06637137: Patient Blood Management in Patients Scheduled for Cardiac Surgery

Recruiting
N/A
464
Europe
Iron, folic acid, b vitamin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Anemia, Anemia, Iron-Deficiency, Iron Deficiency Anemia Treatment, Iron Deficiency Anemia (IDA), Cardiac Surgical Patients, Blood Loss, Surgical
02/27
02/27
Marrone, Giuseppe
ESGiTX, NCT05760235: Prospective Pilot Study for the Evaluation of Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Liver Transplant Candidates

Recruiting
N/A
24
Europe
Endoscopic sleeve gastroplasty (ESG)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Transplantation, Obesity, Bariatric Surgery
10/24
11/24
LivInG, NCT05228587: Indocyanine Green Clearance Test in Liver Transplantation

Recruiting
N/A
162
Europe
Indocyanine green, Injection of Indocyanine green
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Azienda Policlinico Umberto I
Hepatic and Hepatobiliary Disorders
09/24
11/24
graziani, francesca
RICMAF, NCT06806813: Italian Anderson Fabry Disease Cardiovascular Registry

Recruiting
N/A
800
Europe
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Fabry Disease
01/31
12/31
PRO-ACHD, NCT06723704: Prognosis in Adult Patients with Congenital Heart Disease

Recruiting
N/A
450
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Adult Congenital Heart Disease
12/26
12/26
CMPMIRNA, NCT06813443: Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

Recruiting
N/A
700
Europe
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Cardiomyopathies, Amyloidosis Cardiac, Fabry Disease, Arrhythmogenic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Laminopathies, Dystrophia Myotonica, Mitochondrial Cardiomyopathy, Dilated Cardiomyopathy, Sudden Cardiac Death, Heart Transplantation, Glycogen Storage Disease, Infiltrative Cardiomyopathy, Cardiac Magnetic Resonance Imaging, Electrocardiogram, Micro RNA, Echocardiogram
06/27
12/27
ICAR, NCT06894290: International Cardiac Amyloidosis Registry

Recruiting
N/A
300
Europe, Japan
Leiden University Medical Center, Pfizer
Cardiac Amyloidosis
07/26
07/26
Echo-AMY, NCT05760287: Echocardiographic Characterization of Cardiac Amyloidosis

Recruiting
N/A
255
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cardiac Amyloidosis
12/30
02/31
ZOCCO, MARIA ASSUNTA
NCT05977764: Multimodal Ultrasound and Focal Liver Lesions (FLLs)

Recruiting
N/A
110
Europe
Ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Neoplasms
02/23
12/24
NCT05789641: Multimodal Ultrasound and Portal Hypertension

Recruiting
N/A
73
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Portal Hypertension
12/23
12/24
EL-CHIR, NCT06056986: Shear-Wave Elastography in Intestinal Fibrosis Evaluation in Crohn's Disease

Recruiting
N/A
18
Europe
multimodal ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Crohn Disease
12/23
12/24
CELESTIAL, NCT05987501: Multimodal Ultrasound in Inflammatory Bowel Diseases

Recruiting
N/A
50
Europe
Multimodal ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Inflammatory Bowel Diseases
06/24
12/24
SARCOLIVER, NCT06101758: Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the Study

Recruiting
N/A
125
Europe
Handgrip strength test, total body Dual Energy X-Ray Absorptiometry (DXA), Muscle ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma
07/24
07/25
NCT05987514: Multimodal Ultrasound and Hepatocellular Response to Local Treatments

Recruiting
N/A
50
Europe
multimodal ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Hepatocellular Carcinoma
10/24
06/25
NCT05977777: Contrast-enhanced Ultrasound and Pancreatic Lesions

Recruiting
N/A
50
Europe
Contrast- enhanced ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Pancreatic Cancer
11/24
06/25
SARCOPAN, NCT06092307: SARcopenia in Patients With ChrOnic PANcreatitis: the Study

Recruiting
N/A
98
Europe
Bioelectrical impedance, Handgrip strength test, muscle ultrasound.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Pancreatitis
05/25
09/25
McDowell, Rose
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
Kalkavan, Halime
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
Roberts-Thomson
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
cammertoni, federico
LEARNERS, NCT06589323: Residents' Learning Curve of Intraoperative Transit-time Flowmetry and High-frequency Ultrasound in CABG

Recruiting
N/A
80
Europe
Coronary artery bypass graft
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Coronary Artery Disease
10/24
11/24
COLLATERAL, NCT06471062: Transit Time Flow Measurement in Coronary Surgery

Not yet recruiting
N/A
135
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Coronary Artery Disease, Coronary Stenosis, Coronary Bypass Graft Stenosis
05/25
10/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Piperno-Neumann, Sophie
TANGENT, NCT05417789: Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

Recruiting
3
128
Europe, Canada, US, RoW
Emactuzumab, Placebo
SynOx Therapeutics Limited
TGCT
04/26
09/27
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
SARCOME13, NCT03643133 / 2017-001165-24: Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients

Active, not recruiting
2
60
Europe
Mifamurtide, MEPACT, EI or M-API regimen depending on patient age
UNICANCER
Osteosarcoma
03/25
10/33
REGOBONE, NCT02389244 / 2013-003910-42: A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas

Checkmark Data from REGOBONE trial for relapsed advanced or metastatic chordoma at ESMO 2021
Jul 2021 - Jul 2021: Data from REGOBONE trial for relapsed advanced or metastatic chordoma at ESMO 2021
Active, not recruiting
2
163
Europe
Regorafenib, Stivarga, Placebo, Placebo tablet
UNICANCER
Ewing Sarcomas, Chondrosarcomas, Osteosarcomas, Chondroma, CIC-Rearranged Sarcoma
10/24
06/25
IDE196-009, NCT05907954: (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Recruiting
2
82
Europe, Canada, US, RoW
Darovasertib, IDE196, LXS196
IDEAYA Biosciences
Uveal Melanoma
01/26
01/29
CAMPFIRE, NCT05999994: A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Recruiting
2
105
Europe, Japan, US, RoW
Ramucirumab, LY3009806, Cyclophosphamide, Vinorelbine, Gemcitabine, LY188011, Docetaxel, Abemaciclib, LY2835219, Irinotecan, Temozolomide
Eli Lilly and Company
Neoplasms, Child, Adolescent
05/27
05/27
REGOMAIN, NCT04698785: Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

Recruiting
2
36
Europe
Treatment by regorafenib and best supportive care, Experimental arm
Centre Leon Berard
Bone Sarcoma, Osteosarcoma
07/26
07/26
COTESARC, NCT04216953: MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

Active, not recruiting
1/2
320
Europe
Cobimetinib, GDC-0973, Atezolizumab, RO5541267
Centre Leon Berard
Sarcoma,Soft Tissue
02/26
02/27
NCT04879017: FHD-286 in Subjects With Metastatic Uveal Melanoma

Terminated
1
76
Europe, US
FHD-286
Foghorn Therapeutics Inc.
Metastatic Uveal Melanoma
11/23
11/23
REGOSTA, NCT04055220 / 2018-004045-16: Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Recruiting
N/A
168
Europe
Treatment by Regorafenib, Stivarga, Treatment by Placebo, Standard of care
Centre Leon Berard
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma, Chondrosarcoma, Undifferentiated Pleomorphic Sarcoma, Leiomyosarcoma, Angiosarcoma
10/26
10/26
SALOME, NCT04424719: Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse

Recruiting
N/A
700
Europe
Blood test, MRI in routine
Institut Curie
Uveal Melanoma
07/35
07/35
OPTISARC, NCT05272358: Economic Evaluation of Sarcoma Patients Management in France

Recruiting
N/A
2431
Europe
NETSARC network
Centre Leon Berard, École nationale supérieure des Mines Saint-Etienne France, Rennes University Hospital, Assistance Publique - Hôpitaux de Paris
Sarcoma
06/22
02/24
Capogna, Giorgio
NCT04749186: Achieving Lumbar Epidural Block Competency in Inexperienced Trainees After a Structured Teaching Model

Enrolling by invitation
N/A
15
Europe
Compuflo Epidural Training Instrument, Eye tracking glasses, Standardized educational videorecordings, Epidural Simulator
European e-Learning School in Obstetric Anesthesia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Educational Problems
09/22
09/22
NCT05309434: Effects of CPR Coaching on Leader's Performance During Simulated Cardiac Arrest

Not yet recruiting
N/A
40
Europe
Coach
European e-Learning School in Obstetric Anesthesia
Leadership
09/22
10/22
NCT04776382: Eye Movement Modeling Examples as a Teaching Tool

Enrolling by invitation
N/A
15
Europe
EMME (Eye Movement Modeling Examples)
European e-Learning School in Obstetric Anesthesia
Simulation Training
10/22
10/22
Jamal, Rahima
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
NCT01676649: Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Active, not recruiting
2
30
Canada
Ipilimumab, YERVOY, Carboplatin, Paclitaxel
Jewish General Hospital
Untreated Stage III Melanoma or Stage IV Melanoma
02/17
05/26
NCT02617849: Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

Active, not recruiting
2
30
Canada
Pembrolizumab, MK3475, Carboplatin, Paclitaxel
Wilson Miller
Metastatic Malignant Melanoma
12/21
12/25
Canbiome2, NCT06623461: LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

Recruiting
2
128
Canada
Standard of Care Immune Checkpoint Blockade, LND101
Canadian Cancer Trials Group, Canadian Institutes of Health Research (CIHR), Canadian Cancer Society (CCS), Weston Family Foundation
Melanoma
12/28
12/29
NCT04836195: Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma

Completed
1
29
Canada
PCLX-001 - 20mg, zelenirstat, PCLX-001 - 40mg, PCLX-001 - 70mg, PCLX-001 - 100mg, PCLX-001 - 140mg, PCLX-001 - 210mg, PCLX-001 - 280mg
Pacylex Pharmaceuticals, Ozmosis Research Inc.
B-cell Non Hodgkin Lymphoma, Advanced Solid Tumor
10/24
10/24
NCT04862260: Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Active, not recruiting
1
3
Canada
Cholesterol metabolism disruption, A combination of a lipophilic statin (Atorvastatin, Lipitor), a NPC1L1 inhibitor (Ezetimibe, Ezetrol) and a PCSK9 inhibitor (Evolocumab, Repatha) with chemotherapy in pancreatic cancer
CHU de Quebec-Universite Laval, Canadian Institutes of Health Research (CIHR), Biovalorem
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer, Metastatic Cancer
01/25
12/26
Neidhardt, Eve-Marie
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
ABORL, NCT03356223: Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6

Completed
2
25
Europe
Abemaciclib
Centre Leon Berard
Head and Neck Cancer, Advanced Cancer, Metastatic Cancer
11/22
12/22
EBIN, NCT03235245 / 2017-002887-42: Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

Active, not recruiting
2
271
Europe
Nivolumab + Ipilimumab, Encorafenib + Binimetinib
European Organisation for Research and Treatment of Cancer - EORTC
Unresectable Stage III Melanoma, Stage IV Melanoma
10/23
01/27
MOST plus, NCT02029001: Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Recruiting
2
900
Europe
Nilotinib (400 mg BID), Open cohort, Everolimus (10 mg QD), Closed cohort, Sorafenib (400 mg BID), Lapatinib (1500 mg QD), Pazopanib (800 mg QD), Olaparib (300 mg BID), Durvalumab + Tremelimumab
Centre Leon Berard, National Cancer Institute, France
Malignant Solid Neoplasms
01/26
10/27
PROFILER, NCT01774409: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer

Recruiting
N/A
10000
Europe
Blood and tumor samples
Centre Leon Berard
Neoplasms
07/25
07/26
MelBase, NCT02828202: Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Recruiting
N/A
6000
Europe
Biological, Tissular, Quality of life
Assistance Publique - Hôpitaux de Paris, National Cancer Institute (NCI)
Malignant Melanoma
03/26
03/26
Tringali, Andrea
NCT06686810: Endoscopy and Primary Sclerosing Cholangitis

Completed
N/A
118
Europe
Endoscopic Retrogradade CholangioPancreatography (ERCP)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Primary Sclerosing Cholangitis (PSC)
11/24
11/24
STEBINANSIED, NCT05761483: Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.

Recruiting
N/A
40
Europe
ERCP, Biliary stents placement
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Transplant Disorder, Ischemic Cholangiopathy, Non-anastomotic Biliary Stricture, Biliary Stricture, Biliary Stents (Plastic)
10/26
01/28
PROTESIED, NCT05761496: Metal and Plastic Biliary Stents to Drain Malignant Distal Biliary Strictures.

Completed
N/A
871
Europe
Biliary stents insertion
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Biliary Stricture, Stent Stenosis
07/22
12/22
Walker, John R
STOP-GAP, NCT02821013: Duration of Anti-PD-1 Therapy in Metastatic Melanoma

Recruiting
3
614
Canada, RoW
Intermittent PD-1 inhibitor therapy, Continuous PD-1 inhibitor therapy
Canadian Cancer Trials Group, Melanoma and Skin Cancer Trials Limited
Unresectable/Metastatic Melanoma
12/27
12/29
NOD, NCT06633900: Naltrexone for Overdose Prevention

Recruiting
2/3
100
US
IM naltrexone, Usual Care
University of California, San Francisco, National Institute on Drug Abuse (NIDA)
Overdose Accidental
04/27
04/27
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
LATENT, NCT03357757: Avelumab With Valproic Acid in Virus-associated Cancer

Active, not recruiting
2
39
Canada
Valproic Acid, Avelumab
AHS Cancer Control Alberta, EMD Serono
Cancer That is Associated With a Chronic Viral Infection, p16 Positive SCCHN, Squamous Cell Carcinoma of the Cervix, p16 Positive Squamous Cell Carcinoma of the Vagina or Vulva, p16 Positive Squamous Cell Carcinoma of the Penis, p16 Positive Squamous Cell Carcinoma of the Anus or Anal Canal, EBER Positive NPC, EBER Positive Hodgkins and Non-hodgkins Lymphona
03/22
02/27
UNSCARRed, NCT03737721: The Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy

Active, not recruiting
2
20
Canada
Avelumab and Radical radiotherapy
AHS Cancer Control Alberta, EMD Serono, Alberta Cancer Foundation
Squamous Cell Carcinoma of the Skin
11/22
12/24
ACT-FAST, NCT04461418: Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases

Recruiting
2
20
Canada
Glucocorticoid therapy
AHS Cancer Control Alberta
Brain Metastases, Adult
09/24
09/25
CURB-2, NCT05262270: Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder

Recruiting
2
426
US
Extended-Release Naltrexone, XR-NTX, Extended Release Buprenorphine, XR-BUP, Placebo (PLB) Injectable matched to XR-NTX, Injectable matching (to XR-NTX) placebo, Placebo (PLB) Injectable matched to XR-BUP, Injectable matching (to XR-BUP) placebo
University of Texas Southwestern Medical Center, National Institute on Drug Abuse (NIDA)
Cocaine Use Disorder
06/25
09/26
NCT04614584: Mirtazapine and Methamphetamine Drug-drug Interaction Study

Completed
1
15
US
Mirtazapine, Methamphetamine
San Francisco Department of Public Health, University of California, Los Angeles
Methamphetamine Use Disorder, Drug Interaction, Cardiovascular Abnormalities
05/24
05/24
Scambia, Giovanni
NCT04460807 / 2018-000693-30: Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Terminated
3
23
Europe
Exemestane, Mestane, Placebo oral tablet
Ente Ospedaliero Ospedali Galliera, Istituto Di Ricerche Farmacologiche Mario Negri, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Federation of Italian Cooperative Oncology Groups
Ovarian Cancer
04/23
04/23
NCT02584478 / 2021-003871-32: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Active, not recruiting
3
294
Europe, US, RoW
AL3818, Anlotinib Hydrochloride, Anlotinib, Catequentinib, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD), Topotecan, Daily Topotecan, Weekly Topotecan, Carboplatin, Paraplatin, Taxol
Advenchen Laboratories, LLC, Advenchen Laboratories, LLC
Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Cervical Carcinoma
10/24
12/24
FLORA-4, NCT04498117 / 2020-002270-26: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Active, not recruiting
3
615
Europe, Canada, US, RoW
Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo
CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd
Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms
09/25
08/27
NUVOLA, NCT04261465: TRIAL Open-label Multicentre Study

Recruiting
2
35
Europe
Olaparib, Lynparza, Paclitaxel, Carboplatin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
High Grade Serous Ovarian Cancer
12/20
12/22
PYNNACLE, NCT04585750: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

Recruiting
1/2
230
Europe, US, RoW
rezatapopt, PC14586, pembrolizumab, KEYTRUDA®, MK-3475, KEYNOTE-D79, MK-3475-D79
PMV Pharmaceuticals, Inc, Merck Sharp & Dohme LLC
Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor, Lung Cancer, Ovarian Cancer, Endometrial Cancer, Prostate Cancer, Colorectal Cancer, Breast Cancer, Other Cancer, Locally Advanced, Head and Neck Cancer, Gall Bladder Cancer, Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Small Cell Lung Carcinoma, NSCLC, NSCLC (Non-small Cell Lung Cancer), SCLC, Non-Small Cell Lung Carcinoma, Triple Negative Breast Cancer, TNBC, HER2+ Breast Cancer, Non-Small Cell Lung Cancer, ER/PR Positive Breast Cancer, HER2- Breast Cancer, HER2-positive Breast Cancer, HER2-negative Breast Cancer, ER/PR(+), Her2(-) Breast Cancer
03/26
07/26
GO-VAC, NCT04584957: Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.)

Active, not recruiting
N/A
196
Europe
VAC therapy
Catholic University of the Sacred Heart
Wound Infection, Gynecologic Cancer
09/21
09/21
MYLUNAR, NCT04123158: MYometrial Lesion UltrasouNd And mRi

Completed
N/A
2353
Europe
Ultrasound, MRI
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Prof. Antonia Testa, Dr. Daniela Romualdi, Dr. Francesca Ciccarone
Sarcoma Uterus
12/23
12/23
CLESS, NCT04178876: Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( )

Recruiting
N/A
64
Europe
ethanol sclerotherapy, stripping technique
Catholic University of the Sacred Heart
Endometrioma
11/22
06/23
FPG-500, NCT06020625: Mutational Oncology in Clinical Practice

Recruiting
N/A
20000
Europe
Diagnostic Test
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Genome Instability, Genetic Predisposition to Disease, Gene Rearrangement
05/23
01/32
NCT04291612: Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Recruiting
N/A
1400
Europe, US, RoW
Physical exam
Memorial Sloan Kettering Cancer Center
Endometrial Cancer, Endometrioid Adenocarcinoma, Endometrial Cancer Stage I
02/25
02/25
R-LYNUS, NCT06621823: Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies

Recruiting
N/A
160
Europe
image-guided surgery technique
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lymph Node Metastasis, Gynecologic Cancer
12/24
05/26
G-AYA, NCT06594471: Comprehensive Assessment of Clinical Characteristics and Outcomes of Gemelli Adolescents and Young Adults

Not yet recruiting
N/A
500
Europe
Questionnaire on late-term physical effects, Questionnaire on sexual and reproductive health outcomes, Questionnaire on psychological outcomes, Questionnaire on social outcomes
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gynecologic Cancer
09/39
03/40
LYSE, NCT06619002: Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies

Recruiting
N/A
100
Europe
Sentinel lymph node sampling, sentinel lymph node detection, sentinel lymph node dissection, sentinel lymph node biopsy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IHU Strasbourg, University Hospital, Strasbourg
Endometrial Cancer, Cervical Cancer, Deep Learning, Artificial Intelligence
09/26
09/27
LASH, NCT06416748: Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer

Recruiting
N/A
974
Europe
Minimally invasive simple hysterectomy, simple hysterectomy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancer, Cervix Cancer
07/27
07/30
GEN&RARE, NCT06926127: Genomic Profiling of Genetic and Rare Diseases

Recruiting
N/A
1500
Europe
Whole Exome Sequencing (WES)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rare Diseases, Genetic Disease
04/26
02/30
Immuno-Gyn, NCT06737640: Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer

Not yet recruiting
N/A
90
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancer, Endometrial Cancer
12/25
12/26
SOLAR, NCT06832397: Detection of Peritoneal Metastases by Diagnostic LAparoscopy in Patients With Locally Advanced Cervical Carcinoma

Not yet recruiting
N/A
120
Europe
Diagnostic laparoscopy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancer
02/28
02/31
STORY, NCT06802198: A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes

Not yet recruiting
N/A
500
Europe
total hysterectomy, subtotal hysterectomy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fibroid Uterus, Metrorrhagia, Adenomyosis, Benign Gynecologic Neoplasm, Endometriosis, Abnormal Uterine Bleeding
02/28
02/30
IMMUNO_ASSAY, NCT06797479: Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.

Not yet recruiting
N/A
12
NA
Blood samples for the analysis of sildenafil in plasma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gynecological Cancer, Immunotherapy
03/30
12/30
MIPEX, NCT06867445: Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence

Recruiting
N/A
64
Europe
Minimally invasive pelvic exenteration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancers, Vaginal Cancers
03/28
03/31
TAILOR, NCT04555473: Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

Recruiting
N/A
48
Europe
Tumor biopsy, Blood sampling
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organoids, Epithelial Ovarian Cancer
11/21
05/23
Nobile, Stefano
FUSID, NCT06031025: Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.

Recruiting
N/A
71
Europe
Questionnaire, clinical examination
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Functional Gastrointestinal Disorders, Gastroesophageal Reflux, Constipation - Functional, Diarrhea, Dyschezia, Colic, Infantile, Vomiting; Cyclical
09/25
09/25
NCT05760274: Esophageal pH-MII Duration: 12 or 24 Hours?

Completed
N/A
127
Europe
multichannel intraluminal impedance and pH monitoring (MII/pH)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gastro Esophageal Reflux
02/25
02/25
NCT06273202: Ultrasound Monitoring of Muscle Thickness in Premature Patients

Active, not recruiting
N/A
24
Europe
Infant Massage
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Prematurity
06/25
09/25
COLF, NCT05793723: Long-term Respiratory Complications in Infants With Perinatal COVID-19

Active, not recruiting
N/A
40
Europe
Pulmonary function testing device
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
COVID-19, Infant, Newborn, Diseases, Respiratory Function Tests
05/25
05/25
ARTE, NCT06443515: Respiratory Trends During Blood Transfusions in Newborns.

Recruiting
N/A
71
Europe
lung ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Blood Transfusion Complication, Blood Transfusion Associated Adverse Reactions, Respiratory Complication, Respiratory Morbidity
12/25
01/26
ELFIGO, NCT06919757: Early Lung Function Trajectories: Comparison Between Infants With and Without Intrauterine Growth Restriction.

Not yet recruiting
N/A
54
Europe
fetal ultrasound to assess lungs, heart and diaphragm, lung function tests
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Intrauterine Growth Retardation (IUGR), Lung Function Tests, Preterm Infant, Respiratory Monitoring
03/27
03/27
Baurain, Jean Francois
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
NCT06433219: Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

Recruiting
2
60
Europe, US, RoW
Tuvusertib (M1774), M1774, VXc-400, VRT-1363004, substance code MSC2584415A, Niraparib, GSK3985771, MK-4827, Lartesertib (M4076), M4076, substance code MSC2585823A
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Ovarian Cancer
01/28
01/28
Teofili, Luciana
BORN, NCT05100212: umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity

Completed
2
146
Europe
cord blood-RBC concentrates, cord blood packed RBC, adult donor RBC concentrates, adult donor packed RBC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Fresenius Kabi
Retinopathy of Prematurity
01/25
01/25
ATREMA, NCT04355130: Autologous Tansfusion REquirements in Bone MArrow Harvest: The Study

Completed
N/A
7
Europe
Iron, vitamin B12 and acid folic supplementation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Bone Marrow Donors
12/22
12/22
DILEMMA, NCT05835726: Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.

Recruiting
N/A
188
Europe
Daratumumab, Darzalex
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Multiple Myeloma, Daratumumab, Autologous Stem Cell Transplantation, Leukapheresis
12/23
04/24
BLEED, NCT05835882: Blood Salvage From Liver Donors: a Feasibility Pilot Study

Recruiting
N/A
25
Europe
Red Blood Cell concentrates from organ donor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Transplantation, Erythrocyte Transfusion
12/24
06/25
ICARUS-2, NCT06637137: Patient Blood Management in Patients Scheduled for Cardiac Surgery

Recruiting
N/A
464
Europe
Iron, folic acid, b vitamin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Anemia, Anemia, Iron-Deficiency, Iron Deficiency Anemia Treatment, Iron Deficiency Anemia (IDA), Cardiac Surgical Patients, Blood Loss, Surgical
02/27
02/27
Marchetti, Claudia
MITO32, NCT04421547 / 2019-001623-12: Efficacy of Letrozole in Recurrent Ovarian Cancer

Terminated
3
86
Europe
Letrozole 2.5mg, Standard single agent chemotherapy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Epionpharma S.r.l.
Epithelial Ovarian Cancer
11/24
11/24
NUVOLA, NCT04261465: TRIAL Open-label Multicentre Study

Recruiting
2
35
Europe
Olaparib, Lynparza, Paclitaxel, Carboplatin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
High Grade Serous Ovarian Cancer
12/20
12/22
MITO36, NCT04887961: Reprab Study: PLD + Trabectedin Rechallenge

Recruiting
2
64
Europe
PLD and Trabectedin rechallenge
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Relapsed Ovarian Cancer
04/22
04/22
BeLIVE, NCT06836219: Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario

Recruiting
N/A
300
Europe
Consorzio Oncotech
Ovarian Cancer
01/29
01/29
DISC-OVARY, NCT06497270: A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the Trial

Active, not recruiting
N/A
3
Europe
Theca and Granulosa Cell Isolation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
BRCA Mutation, Estrogen Deficiency, Surgical Menopause, Menopause Related Conditions, Menopause, Premature, Ovarian Cancer
06/26
06/27
Immuno-Gyn, NCT06737640: Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer

Not yet recruiting
N/A
90
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cervical Cancer, Endometrial Cancer
12/25
12/26
TUBA-WISP II, NCT04294927: TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

Recruiting
N/A
3000
Europe, US, RoW
Risk-reducing salpingectomy with delayed oophorectomy, Risk-reducing salpingo-oophorectomy
University Medical Center Nijmegen
BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation, BRIP1 Gene Mutation, Ovarian Cancer
02/40
02/40
corsi, filippo
ICARUS-2, NCT06637137: Patient Blood Management in Patients Scheduled for Cardiac Surgery

Recruiting
N/A
464
Europe
Iron, folic acid, b vitamin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Anemia, Anemia, Iron-Deficiency, Iron Deficiency Anemia Treatment, Iron Deficiency Anemia (IDA), Cardiac Surgical Patients, Blood Loss, Surgical
02/27
02/27
Marrone, Giuseppe
ESGiTX, NCT05760235: Prospective Pilot Study for the Evaluation of Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Liver Transplant Candidates

Recruiting
N/A
24
Europe
Endoscopic sleeve gastroplasty (ESG)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Transplantation, Obesity, Bariatric Surgery
10/24
11/24
LivInG, NCT05228587: Indocyanine Green Clearance Test in Liver Transplantation

Recruiting
N/A
162
Europe
Indocyanine green, Injection of Indocyanine green
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Azienda Policlinico Umberto I
Hepatic and Hepatobiliary Disorders
09/24
11/24
graziani, francesca
RICMAF, NCT06806813: Italian Anderson Fabry Disease Cardiovascular Registry

Recruiting
N/A
800
Europe
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Fabry Disease
01/31
12/31
PRO-ACHD, NCT06723704: Prognosis in Adult Patients with Congenital Heart Disease

Recruiting
N/A
450
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Adult Congenital Heart Disease
12/26
12/26
CMPMIRNA, NCT06813443: Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

Recruiting
N/A
700
Europe
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Cardiomyopathies, Amyloidosis Cardiac, Fabry Disease, Arrhythmogenic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Laminopathies, Dystrophia Myotonica, Mitochondrial Cardiomyopathy, Dilated Cardiomyopathy, Sudden Cardiac Death, Heart Transplantation, Glycogen Storage Disease, Infiltrative Cardiomyopathy, Cardiac Magnetic Resonance Imaging, Electrocardiogram, Micro RNA, Echocardiogram
06/27
12/27
ICAR, NCT06894290: International Cardiac Amyloidosis Registry

Recruiting
N/A
300
Europe, Japan
Leiden University Medical Center, Pfizer
Cardiac Amyloidosis
07/26
07/26
Echo-AMY, NCT05760287: Echocardiographic Characterization of Cardiac Amyloidosis

Recruiting
N/A
255
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Cardiac Amyloidosis
12/30
02/31
ZOCCO, MARIA ASSUNTA
NCT05977764: Multimodal Ultrasound and Focal Liver Lesions (FLLs)

Recruiting
N/A
110
Europe
Ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Neoplasms
02/23
12/24
NCT05789641: Multimodal Ultrasound and Portal Hypertension

Recruiting
N/A
73
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Portal Hypertension
12/23
12/24
EL-CHIR, NCT06056986: Shear-Wave Elastography in Intestinal Fibrosis Evaluation in Crohn's Disease

Recruiting
N/A
18
Europe
multimodal ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Crohn Disease
12/23
12/24
CELESTIAL, NCT05987501: Multimodal Ultrasound in Inflammatory Bowel Diseases

Recruiting
N/A
50
Europe
Multimodal ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Inflammatory Bowel Diseases
06/24
12/24
SARCOLIVER, NCT06101758: Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the Study

Recruiting
N/A
125
Europe
Handgrip strength test, total body Dual Energy X-Ray Absorptiometry (DXA), Muscle ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma
07/24
07/25
NCT05987514: Multimodal Ultrasound and Hepatocellular Response to Local Treatments

Recruiting
N/A
50
Europe
multimodal ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Hepatocellular Carcinoma
10/24
06/25
NCT05977777: Contrast-enhanced Ultrasound and Pancreatic Lesions

Recruiting
N/A
50
Europe
Contrast- enhanced ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Pancreatic Cancer
11/24
06/25
SARCOPAN, NCT06092307: SARcopenia in Patients With ChrOnic PANcreatitis: the Study

Recruiting
N/A
98
Europe
Bioelectrical impedance, Handgrip strength test, muscle ultrasound.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Pancreatitis
05/25
09/25
McDowell, Rose
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
Kalkavan, Halime
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
Roberts-Thomson
DAR-UM-2, NCT05987332: IDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma

Recruiting
2/3
420
Europe, Canada, US, RoW
IDE196, Darovasertib, Crizotinib, XALKORI, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Nivolumab, Opdivo, Dacarbazine, DTIC-Dome
IDEAYA Biosciences
Metastatic Uveal Melanoma
01/27
01/28
cammertoni, federico
LEARNERS, NCT06589323: Residents' Learning Curve of Intraoperative Transit-time Flowmetry and High-frequency Ultrasound in CABG

Recruiting
N/A
80
Europe
Coronary artery bypass graft
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Coronary Artery Disease
10/24
11/24
COLLATERAL, NCT06471062: Transit Time Flow Measurement in Coronary Surgery

Not yet recruiting
N/A
135
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Coronary Artery Disease, Coronary Stenosis, Coronary Bypass Graft Stenosis
05/25
10/25
 

Download Options